Latest Spondyloarthropathy Stories
On December 5th, 2014, “Broads for Bones with the Biggest D&*k in Hollywood!” will take place at Three Clubs Cocktail Lounge, 1123 N. Vine St. Hollywood CA 90038.
- Secukinumab is the first selective IL-17A inhibitor to significantly improve signs and symptoms of ankylosing spondylitis (AS) versus placebo in Phase III studies EAST HANOVER, N.J., Nov.
Ankylosing spondylitis is a systemic disease that causes inflammation in the spinal joints and was thought to have affected members of the ancient Egyptian royal families.
NORWALK, Conn., July 31, 2014 /PRNewswire/ -- UBM Medica US announces that Rheumatology Network,
World Autoimmune Arthritis Day (WAAD) is a free global Online Virtual Convention that invites patients and supporters to attend Virtual Presentations and Chat Sessions, download countless educational
- A transitional zone between two communities containing the characteristic species of each.